GOV.UK
New guidance for cervical screening provider leads
PHE has published guidance describing the role and responsibilities of cervical screening provider leads.
HPV
Primary HPV testing update
Ruth Stubbs, PHE's Cervical Screening Programme Manager, shares how the plans for introducing HPV primary screening are coming along.
New guidance to help cervical screening providers reduce cytology backlogs
PHE Screening has published guidance for laboratories and local cervical screening providers to support the option of mitigating against the risk of longer cytology backlogs by using primary HPV screening pilot sites.
HPV primary screening implementation: NHS England announces next steps
NHS England has published a statement regarding commissioning decisions for HPV primary screening in the cervical screening programme.
What GPs need to know about the introduction of primary HPV testing in cervical screening
Cervical screening saves an estimated 5,000 lives a year by detecting abnormalities of the cervix early and referring women for effective treatment.
Deciding how best to roll out HPV testing as the primary cervical screening test
Evidence shows that human papillomavirus (HPV) testing is a better way of identifying women at risk of cervical cancer than the cytology (smear) test that examines cells under a microscope.
NHS Cervical Screening Programme approves new HPV tests and issues guidance for laboratories
Cervical screening saves an estimated 5,000 lives a year by detecting abnormalities of the cervix early and referring women for effective treatment.
International delegates told of HPV primary screening rollout challenges
PHE screening team members and clinicians attended the 40th European Congress of Cytology in Liverpool.